In-vitro diagnostic substance manufacturing in Utah (NAICS 325413)

NAICS 325413 and Utah as a diagnostics join

This page intersects one six-digit industry and one state. $56,353,423.60 is the obligation sum where both filters are true. NAICS 325413 is in-vitro diagnostic substance manufacturing, not pharmaceutical preparation manufacturing and not medical-equipment wholesale. It is not a statewide spending total and not a national NAICS 325413 total. Those parent tables live on Utah federal spending and NAICS 325413.

458 awards against $56.4 million is a mid-thickness manufacturing book, not three oversized vehicles. 458 is an award-record count. Modifications can sit beside base awards. The packet does not say how many unique vendors produced the 458 lines. Reading 458 as factories, ships, or clinics in Utah would confuse actions with establishments.

Utah industries lists other NAICS codes with UT place of performance. All spending ties indexes other state–industry pairs. Do not sum those indexes into $56,353,423.60. The headline remains $56,353,423.60 on 458 awards for this pair alone.

IVD substances, not finished drugs

NAICS 325413 is a Census industry code assigned on the award. NAICS 325413 is in-vitro diagnostic substance manufacturing, not pharmaceutical preparation manufacturing and not medical-equipment wholesale. Pharmaceutical preparation manufacturing (325412) and surgical appliance manufacturing are different codes. Those neighboring codes never enter $56,353,423.60 unless they also appear as 325413, which they do not. Keep the six-digit label when you cite the Utah cell.

IVD substances are reagents and kits at the factory, not a count of tests run in clinics. This packet does not name assays. Dividing $56,353,423.60 by 458 produces about $123,042. That quotient is arithmetic, not a typical Utah contract. There is no median, no top-award table, and no fiscal-year breakout on this packet. Do not treat the mean as a posted unit price.

Utah geography on a 325413 cell

Utah place of performance can cover Salt Lake County, Utah County, or a reporting address. The packet has no campus split. Inside the UT tag, Salt Lake City, Provo, or a named diagnostics campus are not broken out. The packet has one state key. A named city can sit inside $56,353,423.60 only if its awards carry NAICS 325413 and UT — which this narrative cannot verify.

Place-of-performance geography is not the same as contractor headquarters. A firm based elsewhere can perform in Utah, and a Utah address can appear on work done out of state. This join reports the coded pair, not a logistics map. Utah federal spending remains the statewide parent.

Obligations versus outlays for Utah 325413

USAspending obligations are commitments, not checks that have cleared. $56,353,423.60 can include amounts that will be paid later, cancelled, or modified. The packet does not publish outlays. 458 is not a payment count. Quote NAICS 325413 in Utah as obligations and leave fiscal-year folklore off the citation — years are unpublished here.

What the IVD–Utah pair does not prove

The IVD manufacturing–Utah pair does not prove that Utah specialized in this industry because of federal demand, or the reverse. IVD substances are reagents and kits at the factory, not a count of tests run in clinics. This packet does not name assays. Campaign-finance tables are a different dataset; donations do not fund these awards. Keep both sides of the join in any headline: NAICS 325413 and Utah.

How to cite NAICS 325413 in Utah

Cite USAspending.gov, NAICS 325413 (In-Vitro Diagnostic Substance Manufacturing), Utah (UT), $56,353,423.60, and 458 awards. Note that the figures are obligations. Point readers to Utah federal spending, NAICS 325413, Utah industries, and All spending ties rather than collapsing those pages into this cell. Mean per award stays about $123,042 as a ratio only. Readers who reuse IVD manufacturing in Utah | NAICS 325413 should keep both sides of the join in the same sentence, cite USAspending.gov as the source, and treat award rows as records rather than unique vendors. The live hubs linked from this page can refresh the snapshot; this narrative does not invent a fiscal year, a recipient list, or an outlay total that the packet omitted. Place of performance remains a geography tag, not proof that work stayed inside the named state.

Questions

How much has NAICS 325413 obligated in Utah?

The pair totals $56,353,423.60 across 458 awards, per USAspending.gov NAICS industry aggregates by place of performance state. Those are obligations for In-Vitro Diagnostic Substance Manufacturing inside Utah coding, not outlays and not every federal dollar in Utah. Source filings stay on USAspending.gov.

Do 458 awards mean 458 diagnostic tests?

458 award records produced $56,353,423.60. Concentration or dispersion is visible only as that count against that sum. About $123,042 per award is $56,353,423.60 divided by 458, not a typical Utah purchase. The packet does not list unique recipients or a median award.

Is this Utah’s pharmaceutical manufacturing total?

No. $56,353,423.60 is the obligation sum for NAICS 325413 with Utah place of performance on 458 awards. Finished drugs use other codes. A test census is unpublished. Quote in-vitro diagnostic manufacturing and Utah together and keep the obligation label.

Where are the parent Utah and NAICS 325413 tables?

Use Utah federal spending for the statewide industry mix, NAICS 325413 for the national industry page, Utah industries for the state NAICS index, and All spending ties for other joins. This page quotes only the 325413 × UT cell. Original filings remain on USAspending.gov.